bradykinezj
Bradykinezj, commonly referred to as bradykinesia in English, is marked slowness of voluntary movement. It affects initiation, speed, and size of movements, leading to difficulty with tasks such as walking, rising from a chair, or writing. It is a core feature of Parkinsonism and related disorders.
Most often caused by loss of dopamine-producing neurons in the substantia nigra pars compacta, bradykinezj results
Clinically, bradykinezj presents with delayed movement initiation, slow execution, reduced arm swing, micrographia, and short, shuffling
Diagnosis is clinical. Bradykinezj together with tremor at rest, rigidity, or postural instability supports a diagnosis
Treatments aim to restore dopamine signaling and maintain function. Levodopa–carbidopa is the most effective for bradykinezj;